BioRestorative Therapies to Participate at the RHK Capital Disruptive Growth Conference on Dec. 5-6, 2022
29 nov. 2022 11h20 HE
|
BioRestorative Therapies, Inc.
MELVILLE N.Y., Nov. 29, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BioRestorative Therapies, Inc. (Nasdaq: BRTX) today announced that Lance Alstodt, its CEO, will be participating at the RHK...
BioRestorative Therapies Announces Compliance with SEC Reporting Requirements and “Stop Sign” Removal
03 mai 2021 06h00 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., May 03, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Announces Appointment of Nickolay V. Kukekov, Ph.D to its Board of Directors
05 avr. 2021 06h27 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., April 05, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Announces Notice of Allowance for a New Patent Application Related to its Off-the-Shelf ThermoStem® Program
31 mars 2021 07h03 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., March 31, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the...
BioRestorative Therapies Announces Notices of Allowance for Three Patent Applications for its Off-the-Shelf ThermoStem® Program
22 mars 2021 06h00 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., March 22, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the...
BioRestorative Therapies Announces Filing of 2019 Annual Report on Form 10-K
18 mars 2021 16h01 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., March 18, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies,...
BioRestorative Therapies Provides End of Year Shareholder Letter
05 janv. 2021 08h00 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Jan. 05, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Emerges from Chapter 11 Reorganization
20 nov. 2020 07h00 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Nov. 20, 2020 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies,...
BioRestorative Therapies Featured in IEEE Pulse Magazine’s Cover Story About Stem Cell Therapies for Low Back Pain
16 déc. 2019 08h00 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Dec. 16, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies,...
BioRestorative Therapies Receives Patent in Israel For Its Metabolic Program
12 déc. 2019 09h45 HE
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Dec. 12, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...